Comparing Restrictive vs. Liberal Oxygen Strategies for Trauma Patients:
The TRAUMOX2 Trial
Welcome to the website of the randomized, controlled clinical trial Comparing Restrictive vs. Liberal Oxygen Strategies for Trauma Patients: The TRAUMOX2 Trial
This trial website is intended for health care professionals, but feel free to explore the information on the study no matter what background you have
Please contact the study group if you have any queries or questions about the study
ClinicalTrials.gov number: NCT05146700
EudraCT number: 2021-000556-19
The TRAUMOX2 trial results were presented at the Critical Care Reviews Down Under meeting in Melbourne, Australia, 11 December 2024, while simultaneously published online in JAMA.
Link for the full CCR presentation
Link for a quick recap by chief investigator Jacob Steinmetz of the findings
Link to the full paper in JAMA
We are eager to present the results of the TRAUMOX2 trial at the Critical Care Reviews Down Under event in Melbourne, Australia at 09:00 – 10:30, 11 December, 2024, local time!
A free livestream will be available at the Critical Care Reviews website
Please see our animated video on how to enrol and manage trial interventions of trial participants in TRAUMOX2
Overview of recruitment
Recruitment began 7 December, 2021
Last update 15 December, 2023
Inclusion ended 12 September, 2023 at hours 23:59 (CET)
1979 patients were randomised - 1508 patients completed the trial
Latest updates
15 December, 2023
Please click the link below for our 10th newsletter
13 August, 2023
We have reached our inclusion goal of 1420 patients! Inclusion will continue for 30 more days and end 12th of September, 2023 at hours 23:59 (CET)
12 July, 2023
Please click the link below for our 9th newsletter
5 June, 2023
Please click the link below for our 8th newsletter